We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+6.33%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$37.1B
AUM Growth
+$3.97B
Cap. Flow
+$592M
Cap. Flow %
1.59%
Top 10 Hldgs %
8.58%
Holding
2,714
New
178
Increased
1,030
Reduced
953
Closed
205

Top Buys

Rank Stock Value
1
EOG icon
EOG Resources
EOG
+$143M
2
WNR
Western Refining Inc
WNR
+$142M
3
DTV
DIRECTV COM STK (DE)
DTV
+$137M
4
BHI
Baker Hughes
BHI
+$135M
5
POM
PEPCO HOLDINGS, INC.
POM
+$113M

Top Sells

Rank Stock Value
1
BEAM
BEAM INC COM STK (DE)
BEAM
+$215M
2
LSI
LSI CORPORATION
LSI
+$185M
3
OMC icon
Omnicom Group
OMC
+$165M
4
BRE
BRE PROPERTIES INC CL A
BRE
+$95M
5
JOSB
JOS A BANK CLOTHIERS INC
JOSB
+$83M

Sector Composition

Rank Sector Weight
1 Healthcare 14.43%
2 Technology 12.54%
3 Financials 10.16%
4 Energy 9.99%
5 Industrials 8.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NTWK icon
2351
NetSol Technologies
NTWK
$50.6M
$102K ﹤0.01%
26,400
-3,600
-12% -$15.2K
NAVB
2352
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$100K ﹤0.01%
3,385
– –
AMD icon
2353
Advanced Micro Devices
AMD
$789B
$99K ﹤0.01%
23,619
+7,548
+47% +$30.6K
UQM
2354
DELISTED
UQM Technologies, Inc.
UQM
$99K ﹤0.01%
+43,600
New +$96.3K
NWY
2355
DELISTED
New York & Co Inc
NWY
$99K ﹤0.01%
26,800
– –
CERS icon
2356
Cerus
CERS
$474M
$98K ﹤0.01%
23,501
-33,500
-59% -$143K
SPRT
2357
DELISTED
support.com, Inc.
SPRT
$95K ﹤0.01%
11,667
– –
CASC
2358
DELISTED
Cascadian Therapeutics, Inc.
CASC
$95K ﹤0.01%
+4,867
New +$85.9K
CBR
2359
DELISTED
CIBER Inc.
CBR
$94K ﹤0.01%
19,080
+300
+2% +$1.36K
CLIR icon
2360
ClearSign Technologies
CLIR
$25.5M
$92K ﹤0.01%
1,000
– –
REFR icon
2361
Research Frontiers
REFR
$17M
$92K ﹤0.01%
15,100
– –
VSTM icon
2362
Verastem
VSTM
$592M
$92K ﹤0.01%
850
– –
TEAR
2363
DELISTED
TearLab Corporation
TEAR
$91K ﹤0.01%
1,866
-4,520
-71% -$221K
SCMP
2364
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
$90K ﹤0.01%
13,000
-5,100
-28% -$36.1K
RNWK
2365
DELISTED
RealNetworks Inc
RNWK
$89K ﹤0.01%
32,490
– –
CYTK icon
2366
Cytokinetics
CYTK
$10.4B
$87K ﹤0.01%
18,293
-9,700
-35% -$59.2K
FMD
2367
DELISTED
FIRST MARBLEHEAD CORP COM STK NEW (DE)
FMD
$87K ﹤0.01%
28,435
– –
TNAV
2368
DELISTED
Telenav Inc.
TNAV
$86K ﹤0.01%
15,100
– –
OPTT icon
2369
Ocean Power Technologies
OPTT
$49.9M
$85K ﹤0.01%
+259
New +$127K
ENZ
2370
DELISTED
Enzo Biochem, Inc.
ENZ
$83K ﹤0.01%
+15,800
New +$68.3K
MRGE
2371
DELISTED
MERGE HEALTHCARE INC COM STK (WI)
MRGE
$82K ﹤0.01%
35,946
-10,600
-23% -$24.1K
EDMC
2372
DELISTED
EDUCATION MGMT CORP NEW COM STK (PA)
EDMC
$81K ﹤0.01%
48,056
-22,800
-32% -$61.4K
BIOL
2373
DELISTED
Biolase, Inc.
BIOL
$80K ﹤0.01%
3
– –
BPZ
2374
DELISTED
BPZ RESOURCES INC COM STK
BPZ
$79K ﹤0.01%
+25,500
New +$74.1K
PGNX
2375
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$78K ﹤0.01%
18,100
-42,600
-70% -$163K
93 94
95
96 97

Similar funds

CTC (Chicago Trading Company)
CTC (Chicago Trading Company) Chicago, Illinois $217B AUM 46.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $208B AUM 16.12% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

AQR Capital Management's Q2 2014 Portfolio in Review

As of Q2 2014, AQR Capital Management held 2,714 positions worth $37.1B, up 12% from $33.1B the previous quarter. Its ten largest holdings account for 8.6% of the portfolio.

AQR Capital Management's Q2 2014 filing shows 178 new, 1,030 increased, 953 reduced and 205 closed positions. Its largest new stake was AstraZeneca: 1,186,418 shares worth $88.2M. The largest sale was BEAM INC COM STK (DE), an estimated $215M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • AQR Capital Management's largest Q2 2014 buy was AstraZeneca: 1,186,418 shares worth $88.2M.
  • AQR Capital Management added most to EOG Resources in Q2 2014, an estimated $143M increase.
  • AQR Capital Management's biggest Q2 2014 reduction was Omnicom Group, cutting an estimated $165M.
  • AQR Capital Management fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $215M.
  • AQR Capital Management's ten largest holdings make up 8.6% of its $37.1B portfolio in Q2 2014.
  • AQR Capital Management opened 178 new positions and closed 205 in Q2 2014.
  • AQR Capital Management's portfolio value rose 12% quarter-over-quarter to $37.1B.

Based on AQR Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.